Back to Journals » Drug Design, Development and Therapy » Volume 15
Original Research
A Retrospective Cohort Study Evaluates Clinical Value of Anlotinib in Persistent, Metastatic, or Recurrent Cervical Cancer After Failure of First-Line Therapy
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
4,696 | Dovepress* | 4,283+ | 212 | 4,495 | |
PubMed Central* | 413 | 189 | 602 | ||
Totals | 4,696 | 401 | 5,097 | ||
*Since 16 November 2021 |
View citations on PubMed Central and Google Scholar